Healthcare, Regulatory and Reimbursement Landscape - Vietnam
GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Vietnam". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of Vietnam. It identifies the key trends in the healthcare market of Vietnam and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the country. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.
The population of Vietnam was approximately 86.5 million in 2010, making it the 13th most populated country in the world. This increase in the population is primarily due to a high birth rate and an increase in life expectancy. An increasing disease burden is a matter of concern for policy planners in Vietnam. The pharmaceutical market in the country was $1.9 billion in 2010 and is expected to reach approximately $5.8 billion by 2020 at a projected CAGR of 12%.
The positive trend in the healthcare market of Vietnam can be primarily attributed to -
Increasing coverage of public health insurance in the country
High expenditure on healthcare
Government initiatives for the prevention and management of chronic diseases
An improved and updated regulatory environment
The report provides information on the healthcare, regulatory and reimbursement landscape of Vietnam. The scope of the report includes -
An overview of the pharmaceutical market of Vietnam including market size and market segmentation, as well as key drivers and barriers.
Profile and SWOT analysis of the major players in the pharmaceutical market. The key players covered are Vinapharm, Pfizer, Sanofi, Novartis and Merck & Co.
An insightful review of the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and the market authorization process for a new drug and medical devices in Vietnam.
A detailed analysis of the political and economic environment of Vietnam including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
An overview of the opportunities and challenges for growth that exist in the healthcare market of Vietnam.
Reasons to buy
This report comprehensively covers the pharmaceutical market of Vietnam. It will enhance your decision making capability and will allow you to -
Develop business strategies by understanding the trends shaping and driving the healthcare market of Vietnam.
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the Vietnamese healthcare market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Organize your sales and marketing efforts by identifying the market categories and segments that present the maximum opportunities for consolidations, investments and strategic partnerships.
Identify, understand and capitalize on the opportunities and challenges in the healthcare market of Vietnam.
Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 Report Guidance 9
3 Overview of the Pharmaceutical and Medical Device Markets 10
3.1 Pharmaceutical Market 10
3.1.1 Market Overview 10
3.1.2 Supply Channels 14
3.1.3 Market Segments 15
3.1.4 Overview of Major Disease Areas 18
3.1.5 Major Players 20
3.2 Medical Device Market 47
3.3 Market Drivers and Barriers 47
3.3.1 Drivers 47
3.3.2 Barriers 48
4 Market Access 50
4.1 Reimbursement and Payer Landscape 50
4.1.1 Overview of Healthcare System 50
4.1.2 Reimbursement Process 51
4.1.3 Overview of Insurance Providers 52
4.1.4 Patient Share in Healthcare Spending 56
4.1.5 Drug Price Trend 57
4.1.6 Pricing Policies 58
4.2 Regulatory Landscape 58
4.2.1 Overview of Regulatory Agencies 58
4.2.2 New Drug Approval Process 59
4.2.3 Drug Registration Process for Generics 61
4.2.4 Licensing Process for Pharmaceutical Manufacturing 64
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 64
4.2.6 Intellectual Property Rights 65
4.2.7 Clinical Trial Regulations 69
4.2.8 Pharmaceutical Advertising Regulations 70
4.2.9 Pharmacy Regulations 71
4.2.10 Labeling and Packaging Regulations 72
5 Country Analysis 74
5.1 Political Environment 74
5.1.1 Political Structure 74
5.1.2 Analysis of the Current Political Environment 74